Commission Implementing Decision (EU) 2016/1190 of 19 July 2016 authorising the placing on the market of trans-resveratrol as a novel food ingredient under Regulation (EC) No 258/97 of the European Parliament and of the Council (notified under document C(2016) 4567)
Data as of 2026-07-04 · Compiled from an official source version. Later amendments or repeals may not be reflected; the official text prevails. · Read the official text ↗
Trans -resveratrol as specified in the Annex to this Decision may be placed on the market in the Union as a novel food ingredient to be used in food supplements in capsule or tablet form intended for adult population only with a maximum dose of 150 mg per day without prejudice to the provisions of Directive 2002/46/EC.
1. The designation of trans -resveratrol authorised by this Decision on the labelling of the foodstuffs containing it shall be ‘ trans -resveratrol’. 2. The labelling of food supplements containing trans -resveratrol shall bear a statement that people using medicines should only consume the product under medical supervision.
This Decision is addressed to DSM Nutritional Products Ltd, Heanor Gate Ind. Est. Heanor, Derbyshire, United Kingdom.
ANNEX SPECIFICATION OF TRANS -RESVERATROL Definition: Chemical name 5-[(E)-2-(4-hydroxyphenyl)ethenyl]benzene-1,3-diol Chemical formula C 14 H 12 O 3 Molecular weight 228,25 Da CAS No 501-36-0 Description: Trans -resveratrol is off-white to beige crystals. Purity: Trans -resveratrol Not less than 99 % Total by-products (related substances) Not more than 0,5 % Any single related substance Not more than 0,1 % Lead Not more than 1 ppm Mercury Not more than 0,1 ppm Cadmium Not more than 0,5 ppm Arsenic Not more than 1 ppm Loss on drying Not more than 0,5 % Sulphated ash Not more than 0,1 % Diisopropylamine Not more than 50 mg/kg
Source: EUR-Lex (Publications Office of the EU), © European Union, reuse permitted under Commission Decision 2011/833/EU.